Putnam Investments LLC Igm Biosciences, Inc. Transaction History

Putnam Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $48,604 - $77,650	7,298 Added 25.01%	36,474 $304,000
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $75,469 - $119,252	8,518 Added 41.23%	29,176 $269,000
Q1 2023 May 22, 2023	BUY	$13.74 - $25.76 $75,707 - $141,937	5,510 Added 36.37%	20,658 $283,000
Q4 2022 Feb 14, 2023	SELL	$15.45 - $26.02 $78,594 - $132,363	-5,087 Reduced 25.14%	15,148 $257,000
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $5,489 - $9,615	-356 Reduced 1.73%	20,235 $460,000
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $110,884 - $213,078	8,356 Added 68.3%	20,591 $371,000
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $28,208 - $62,492	2,102 Added 20.74%	12,235 $327,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $279,569 - $672,729	10,133 New	10,133 $297,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.